BiotechTube

donepezil hcl

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dementia Associated With Cerebrovascular Disease

Conditions

Dementia Associated With Cerebrovascular Disease

Trial Timeline

May 1, 2004 → Aug 1, 2005

NCT ID
NCT00188812

About donepezil hcl

donepezil hcl is a phase 3 stage product being developed by Eisai for Dementia Associated With Cerebrovascular Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00188812. Target conditions include Dementia Associated With Cerebrovascular Disease.

What happened to similar drugs?

9 of 20 similar drugs in Dementia Associated With Cerebrovascular Disease were approved

Approved (9) Terminated (1) Active (10)
✅E2020 + PlaceboEisaiApproved
✅donepezil hydrochloride (Aricept)EisaiApproved
✅MecobalaminEisaiApproved
✅Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
✅Risperdal,reminylJohnson & JohnsonApproved
✅ENA713NovartisApproved
✅Rivastigmine Patch 9.5 cm2NovartisApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT02097056ApprovedCompleted
NCT00571064ApprovedCompleted
NCT00188812Phase 3Completed

Competing Products

20 competing products in Dementia Associated With Cerebrovascular Disease

See all competitors
ProductCompanyStageHype Score
[18F]NAV4694Navidea BiopharmaceuticalsPhase 3
26
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
ATH-1017 + PlaceboLeonaBioPhase 2
17
IGC AD1 + PlaceboIGC PharmaPhase 1
19
E2020 + PlaceboEisaiApproved
43
ARICEPTEisaiPhase 3
40
RasagilineEisaiPhase 2
35
Donepezil HydrochlorideEisaiPre-clinical
26
Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placeboEisaiPhase 3
40
E2020 + E2020EisaiPhase 2
35
donepezil hydrochloride (Aricept)EisaiApproved
43
3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + PlaceboEisaiPhase 2
35
E2020 + E2020EisaiPhase 3
40
Irsenontrine + PlaceboEisaiPhase 2
35
E2020EisaiPhase 2
35
MecobalaminEisaiApproved
43
E2020 + PlaceboEisaiPhase 3
40
Donepezil HydrochlorideEisaiPhase 3
40
Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
43